← Eichor
Study identifier: NCT00730678 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pharmacogenetic Determinants Of Treatment Response In Children

Condition: All Malignancies · Children Being Treated for Catastrophic Illness  ·  Sponsor: St. Jude Children's Research Hospital

PhaseN/A
Planned participants8800
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.

This description comes directly from the study's public registry record.

Talk to the study team

Jun J. Yang, Ph. D.  ·  888-226-4343  ·  referralinfo@stjude.org

Always discuss trial participation with your own doctor first.

Locations (1)

St. Jude Children's Research HospitalMemphis, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00730678